Studies suggest that ICT may induce p53 activation via the ROS/p38 MAPK signaling axis, promote p53 phosphorylation, inhibit MDM2 mediated p53 degradation, and suppress aerobic glycolysis and HCC biological behaviors in a p53-dependent manner (163). This evidence concerns the gene MDM2 and hepatocellular carcinoma.